Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT02353728
Title	Stem Cell Monitoring for CML Patients Undergoing Nilotinib Therapy
Recruitment	Completed
Gender	both
Phase	Phase II
Variant Requirements	No
Sponsors	Weill Medical College of Cornell University
Indications	chronic myeloid leukemia
Therapies	Nilotinib
Age Groups:	adult
Covered Countries	USA

Filter rows:

Showing 1 to 1 of 1 entries

Facility	Status	City	State	Zip	Country	Details
Weill Cornell Medical College		New York	New York	10065	United States	Details

Showing 1 to 1 of 1 entries

Filter rows:

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field